Wikidata

(Q42869821)

English

Targeted therapies: PARP inhibitor olaparib is safe and effective in patients with BRCA1 and BRCA2 mutations

scientific article published on October 2010

In more languages

Statements

title
Targeted therapies: PARP inhibitor olaparib is safe and effective in patients with BRCA1 and BRCA2 mutations (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20922827
retrieved
9 November 2017
publication date
1 October 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
20922827
retrieved
9 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42869821&oldid=1973014362"